AEON Biopharma (AEON) Institutional Ownership $0.60 -0.04 (-6.72%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$0.59 -0.01 (-0.84%) As of 03/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$481.13MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$851.16M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter Remove Ads AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/25/2025 Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/19/2025 Formidable Asset Management LLC689,182$372K0.1%+76.8%0.862% 2/17/2025 Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/14/2025 Blue Owl Capital Holdings LP3,049,361$1.65M0.4%-8.7%3.813% 11/16/2024 Geode Capital Management LLC243,168$255K0.0%+30.1%0.622% 11/15/2024 Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202% 11/15/2024 HighTower Advisors LLC23,776$25K0.0%N/A0.061% 11/7/2024 Caprock Group LLC62,686$66K0.0%N/A0.160% 8/14/2024 Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230% 5/17/2024 Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024 Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024 Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023 Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward)Remove Ads AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, 10 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), Blue Owl Capital Holdings LP ($1.65M), Polar Asset Management Partners Inc. ($1.49M), Formidable Asset Management LLC ($372K), Geode Capital Management LLC ($255K), and Shaolin Capital Management LLC ($248K).Learn more on AEON's institutional investors. What percentage of AEON Biopharma stock is owned by institutional investors? 22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma stock? The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($363.71K), Caprock Group LLC ($62.69K), Geode Capital Management LLC ($56.31K), and HighTower Advisors LLC ($23.78K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 4,730,690 shares in the last 24 months. This purchase volume represents approximately $1.99B in transactions. Which AEON Biopharma major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Polar Asset Management Partners Inc. ($1.75M), Shaolin Capital Management LLC ($895.74K), Blue Owl Capital Holdings LP ($291.84K), Davidson Kempner Capital Management LP ($276.62K), and Formidable Asset Management LLC ($6.12K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 3,219,861 shares in the last 24 months. This volume of shares sold represents approximately $854.33M in transactions. Related Companies CDT Major Shareholders OGEN Major Shareholders PLRZ Major Shareholders GNPX Major Shareholders LIPO Major Shareholders UPXI Major Shareholders THAR Major Shareholders PBM Major Shareholders MTNB Major Shareholders LIXT Major Shareholders This page (NASDAQ:AEON) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AEON Stock Free AEON Stock Alerts